Puriblood Medical Co., Ltd. (TPEX:6847)
74.10
+0.60 (0.82%)
Feb 11, 2026, 2:56 PM CST
Puriblood Medical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 80.75 | 86.61 | 117.48 | 99.5 | 131.87 | 99.84 |
Cash & Short-Term Investments | 80.75 | 86.61 | 117.48 | 99.5 | 131.87 | 99.84 |
Cash Growth | -15.28% | -26.28% | 18.07% | -24.55% | 32.09% | 654.79% |
Accounts Receivable | 2.88 | 14.72 | 8.4 | 18.47 | 8.14 | 15.28 |
Other Receivables | 0.22 | 0.18 | 0.15 | 0.11 | 0.05 | 0.41 |
Receivables | 3.1 | 14.9 | 8.56 | 18.57 | 8.19 | 15.69 |
Inventory | 45.42 | 32.42 | 24.25 | 30.86 | 17.36 | 5.39 |
Prepaid Expenses | - | - | 4.37 | 24.61 | 17.07 | 0.89 |
Other Current Assets | 3.98 | 4.12 | - | 27.72 | - | - |
Total Current Assets | 133.25 | 138.05 | 154.66 | 201.26 | 174.5 | 121.81 |
Property, Plant & Equipment | 47.36 | 49.9 | 50.78 | 52.99 | 57.32 | 57.74 |
Long-Term Investments | 59.69 | 55.8 | 39.2 | 46.91 | 23.48 | 5.46 |
Other Intangible Assets | 8.51 | 9.68 | 12.43 | 15.4 | 9.08 | 9.02 |
Long-Term Deferred Tax Assets | 3.22 | 3.14 | 2.43 | 1.29 | - | - |
Other Long-Term Assets | 1.69 | 2.58 | 6.02 | 2.66 | 1.23 | 2.08 |
Total Assets | 253.71 | 259.15 | 265.51 | 320.5 | 265.6 | 196.11 |
Accounts Payable | 9.8 | 7.95 | 15.07 | 3.8 | 1.94 | 0.56 |
Accrued Expenses | - | 13.44 | - | - | - | - |
Short-Term Debt | 5 | - | - | - | - | - |
Current Portion of Long-Term Debt | 6.99 | 4.49 | 6.66 | 4.6 | 2.46 | 2.29 |
Current Portion of Leases | 1.33 | 1.32 | 1.28 | 1.25 | 1.21 | 0.86 |
Current Unearned Revenue | 9.16 | 0.76 | 0.51 | 8.39 | 0.98 | 1 |
Other Current Liabilities | 15.1 | 8.32 | 16.38 | 16.63 | 15.27 | 11.71 |
Total Current Liabilities | 47.38 | 36.26 | 39.89 | 34.66 | 21.85 | 16.42 |
Long-Term Debt | 22.42 | 26.33 | 22.67 | 28.46 | 3.06 | 5.63 |
Long-Term Leases | 19.04 | 19.72 | 21.03 | 22.31 | 23.55 | 25.09 |
Pension & Post-Retirement Benefits | 1.49 | 1.38 | 0.76 | 0.34 | 0.21 | - |
Long-Term Deferred Tax Liabilities | - | 0.07 | 0 | 1.69 | - | - |
Other Long-Term Liabilities | - | - | - | - | 0.44 | 4.81 |
Total Liabilities | 90.33 | 83.75 | 84.35 | 87.47 | 49.11 | 51.94 |
Common Stock | 142.3 | 142.3 | 142.3 | 142.3 | 142.3 | 86 |
Additional Paid-In Capital | 41.36 | 38.86 | 177.83 | 177.83 | 177.83 | 99.57 |
Retained Earnings | -20.29 | -5.76 | -138.97 | -87.1 | -103.63 | -65.39 |
Total Common Equity | 163.38 | 175.4 | 181.16 | 233.03 | 216.5 | 120.17 |
Shareholders' Equity | 163.38 | 175.4 | 181.16 | 233.03 | 216.5 | 144.17 |
Total Liabilities & Equity | 253.71 | 259.15 | 265.51 | 320.5 | 265.6 | 196.11 |
Total Debt | 54.78 | 51.85 | 51.64 | 56.61 | 30.28 | 33.86 |
Net Cash (Debt) | 25.97 | 34.77 | 65.84 | 42.89 | 101.59 | 65.98 |
Net Cash Growth | -45.49% | -47.20% | 53.53% | -57.79% | 53.99% | - |
Net Cash Per Share | 1.82 | 2.44 | 4.63 | 3.01 | 8.72 | 7.67 |
Filing Date Shares Outstanding | 14.23 | 14.23 | 14.23 | 14.23 | 14.23 | 8.6 |
Total Common Shares Outstanding | 14.23 | 14.23 | 14.23 | 14.23 | 14.23 | 8.6 |
Working Capital | 85.87 | 101.79 | 114.76 | 166.6 | 152.65 | 105.39 |
Book Value Per Share | 11.48 | 12.33 | 12.73 | 16.38 | 15.21 | 13.97 |
Tangible Book Value | 154.87 | 165.72 | 168.73 | 217.63 | 207.42 | 111.15 |
Tangible Book Value Per Share | 10.88 | 11.65 | 11.86 | 15.29 | 14.58 | 12.92 |
Machinery | 31.21 | 30.94 | 26.67 | 24.43 | 23.97 | 21 |
Construction In Progress | - | - | - | - | - | 6.6 |
Leasehold Improvements | 17.54 | 17.54 | 17.3 | 16.73 | 16.81 | 9.05 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.